Oppenheimer Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
54,041
-18,711
| -26% | -$349K | 0.01% | 748 |
|
|
2025
Q1 | $1.39M | Buy |
72,752
+11,048
| +18% | +$212K | 0.02% | 633 |
|
|
2024
Q4 | $2.22M | Buy |
61,704
+2,612
| +4% | +$94.1K | 0.03% | 498 |
|
|
2024
Q3 | $2.51M | Buy |
59,092
+9,899
| +20% | +$420K | 0.03% | 478 |
|
|
2024
Q2 | $1.98M | Buy |
49,193
+8,813
| +22% | +$355K | 0.03% | 525 |
|
|
2024
Q1 | $1.43M | Buy |
40,380
+13,277
| +49% | +$470K | 0.02% | 588 |
|
|
2023
Q4 | $802K | Buy |
+27,103
| New | +$802K | 0.01% | 767 |
|
|
2023
Q2 | – | Sell |
-5,259
| Closed | -$214K | – | 1164 |
|
|
2023
Q1 | $214K | Buy |
+5,259
| New | +$214K | ﹤0.01% | 1040 |
|
|
2020
Q1 | – | Sell |
-296
| Closed | -$18K | – | 1634 |
|
|
2019
Q4 | $18K | Sell |
296
-91
| -24% | -$5.53K | ﹤0.01% | 1463 |
|
|
2019
Q3 | $23K | Buy |
387
+31
| +9% | +$1.84K | ﹤0.01% | 1448 |
|
|
2019
Q2 | $23K | Buy |
356
+102
| +40% | +$6.59K | ﹤0.01% | 1464 |
|
|
2019
Q1 | $16K | Sell |
254
-112
| -31% | -$7.06K | ﹤0.01% | 1472 |
|
|
2018
Q4 | $14K | Buy |
+366
| New | +$14K | ﹤0.01% | 1492 |
|
|
2017
Q2 | – | Sell |
-2
| Closed | – | – | 1723 |
|
|
2017
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1697 |
|